ACEA Biosciences is pioneering the development and commercialization of high performance, cutting edge cell analysis instruments for life science research and clinical diagnostics.
xCELLigence® Real-Time Cell Analysis (RTCA) instruments enable label-free, real-time monitoring of cell proliferation, cell size/morphology, cell-substrate attachment quality, and cell invasion/migration. The flexibility, sensitivity, and reproducibility of RTCA make it a standout amongst cell-based assay platforms.
ACEA’s line of NovoCyte® Flow Cytometers is raising the bar for what is expected of benchtop machines by designing and producing high performance, customizable benchtop cytometers at accessible price points. By including features such as 15 fluorescence detection channels with 3 lasers, direct volumetric based cell counting, and a versatile high throughput walkaway autosampler,
xCELLigence and NovoCyte instruments are currently being used worldwide in academic, industrial, and hospital labs for preclinical drug discovery and development, toxicology, safety pharmacology, disease studies, clinical diagnostics, and basic research.
